Zorggroep Twente
Welcome,         Profile    Billing    Logout  
 6 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Veldhuisen, Dirk J van
DECISION, NCT03783429: Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the Netherlands

Active, not recruiting
4
982
Europe
Digoxin, Placebos
University Medical Center Groningen, Disphar International B.V., Teva Nederland BV, Tiofarma BV, Netherlands Heart Foundation, Werkgroep Cardiologische centra Nederland
Heart Failure
07/25
07/25
BEAT-IT, NCT06065124: Bariatric Surgery Evaluation and Assessment of Treatment Efficacy - Intervention Trial

Not yet recruiting
N/A
108
Europe
Bariatric surgery strategy
University Medical Center Groningen, Rijnstate Hospital
Heart Failure With Preserved Ejection Fraction, Atrial Fibrillation
10/27
10/27
Heerspink, Hiddo J Lambers
NCT04620590: An Open Label Phase IV Study to Evaluate Dapagliflozin Treatment in Type 2 Diabetes Mellitus Patients With Impaired Renal Function

Recruiting
4
17
Canada
Dapagliflozin 10 MG [Farxiga]
George Clinical Pty Ltd, University Medical Center Groningen, Ground Zero Pharmaceuticals
Diabetes Mellitus, Type 2, Impaired Renal Function
03/22
04/22
Optimize@Home, NCT06094920: Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial

Enrolling by invitation
4
10
Europe
Empagliflozin 10 MG, Jardiance, A10BK03, (2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol, Finerenone, Kerendia, C03DA05, (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide, Withings BPM Connect, Withings Body, PeeSpot Urine Collection Device, Hem-Col Capillary Blood Collection Device, Questionnaire: participants' perspectives toward the feasibility of participation in a trial at home with digital technologies
University Medical Center Groningen, Boehringer Ingelheim
Diabetes Mellitus Type 2 With Proteinuria, Diabetes Mellitus, Type 2, Diabetes Mellitus, Diabetes, Diabetes Complications, Albuminuria, Chronic Kidney Diseases, Chronic Kidney Disease Due to Type 2 Diabetes Mellitus, Chronic Kidney Disease stage3, Chronic Kidney Disease stage4, CKD, CKD Stage 3, CKD Stage 4
10/24
11/24
CAPTIVATE, NCT06058585: The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect

Recruiting
3
1000
RoW
Finerenone, BAY94-8862, Placebo Finerenone, Endothelin Receptor Antagonist, Placebo Endothelin Receptor Antagonist
The George Institute
Chronic Kidney Diseases
08/28
12/28
ZODIAC, NCT05570305: Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria

Enrolling by invitation
2
38
Europe, Canada, US
Zibotentan, Dapagliflozin, Placebo, Dapagliflozin and Zibotentan
University Medical Center Groningen, AstraZeneca
Chronic Kidney Diseases
04/24
09/24
ASPIRE, NCT06072326: Ambrisentan Sotagliflozin and Prevention of Renal Injury; a Randomized Evaluation

Not yet recruiting
2
36
Europe, Canada, US
Sotagliflozin, Ambrisentan, Ambrisentan and Sotagliflozin
University Medical Center Groningen, Juvenile Diabetes Research Foundation, Lexicon Pharmaceuticals
Type 1 Diabetes Mellitus With Diabetic Nephropathy
03/25
03/25
NCT04389827: Global Kidney Patient Trials Network

Recruiting
N/A
6000
RoW
The George Institute, George Clinical Pty Ltd
Kidney Diseases
04/25
04/30
Wagenaar, Nils
No trials found

Download Options